{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:40:10Z","timestamp":1790433610828,"version":"4.1.0"},"reference-count":170,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81771650"],"award-info":[{"award-number":["81771650"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010270","name":"Capital Health Research and Development of Special Fund","doi-asserted-by":"publisher","award":["2018-1-4091"],"award-info":[{"award-number":["2018-1-4091"]}],"id":[{"id":"10.13039\/501100010270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1002104"],"award-info":[{"award-number":["2018YFC1002104"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1002106"],"award-info":[{"award-number":["2018YFC1002106"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Innovation"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.xinn.2021.100091","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T22:27:20Z","timestamp":1612909640000},"page":"100091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Clinical Applications of Serum Anti-M\u00fcllerian Hormone Measurements in Both Males and Females: An Update"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3310-0828","authenticated-orcid":false,"given":"Huiyu","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannan","family":"Alpadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xinn.2021.100091_bib1","doi-asserted-by":"crossref","first-page":"e1001356","DOI":"10.1371\/journal.pmed.1001356","article-title":"National, regional, and global trends in infertility prevalence since 1990: a systematic analysis of 277 health surveys","volume":"9","author":"Mascarenhas","year":"2012","journal-title":"PLoS Med."},{"key":"10.1016\/j.xinn.2021.100091_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.maturitas.2015.07.019","article-title":"Menopause prediction and potential implications","volume":"82","author":"Daan","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/j.xinn.2021.100091_bib3","doi-asserted-by":"crossref","first-page":"e19096","DOI":"10.2196\/19096","article-title":"An ovarian reserve assessment model based on anti-mullerian hormone levels, follicle-stimulating hormone levels, and age: retrospective cohort study","volume":"22","author":"Xu","year":"2020","journal-title":"J.\u00a0Med. Internet Res."},{"key":"10.1016\/j.xinn.2021.100091_bib4","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s10815-020-01700-1","article-title":"A novel mathematical model of true ovarian reserve assessment based on predicted probability of poor ovarian response: a retrospective cohort study","volume":"37","author":"Xu","year":"2020","journal-title":"J.\u00a0Assist Reprod. Genet."},{"key":"10.1016\/j.xinn.2021.100091_bib5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3181\/00379727-66-16071","article-title":"The age factor in the castration of male rabbit fetuses","volume":"66","author":"Jost","year":"1947","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.xinn.2021.100091_bib6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/mrd.22076","article-title":"Regulation of the ovarian reserve by members of the transforming growth factor beta family","volume":"79","author":"Pangas","year":"2012","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.xinn.2021.100091_bib7","doi-asserted-by":"crossref","first-page":"a022251","DOI":"10.1101\/cshperspect.a022251","article-title":"The TGF-beta family in the reproductive tract","volume":"9","author":"Monsivais","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.xinn.2021.100091_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/269411a0","article-title":"Anti-Mullerian hormone is a functional marker of foetal Sertoli cells","volume":"269","author":"Tran","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.xinn.2021.100091_bib9","first-page":"3836","article-title":"Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells","volume":"84","author":"Rajpert-De Meyts","year":"1999","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xinn.2021.100091_bib10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/humupd\/dmq034","article-title":"AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis","volume":"17","author":"Broer","year":"2011","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.xinn.2021.100091_bib11","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/humupd\/dmt037","article-title":"Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice","volume":"20","author":"La Marca","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.xinn.2021.100091_bib12","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","article-title":"Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary","volume":"140","author":"Durlinger","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.xinn.2021.100091_bib13","doi-asserted-by":"crossref","first-page":"S424","DOI":"10.1016\/j.fertnstert.2005.07.1108","article-title":"Lack of AMH response to EFORT suggests that AMH production is gonadotropin-independent in adult women","volume":"84","author":"Fanchin","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2265.2006.02533.x","article-title":"Anti-Mullerian hormone (AMH) in female reproduction: is measurement of circulating AMH a useful tool?","volume":"64","author":"La Marca","year":"2006","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.xinn.2021.100091_bib15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0378-3782(93)90204-8","article-title":"Anti-Mullerian hormone in early human development","volume":"33","author":"Josso","year":"1993","journal-title":"Early Hum. Dev."},{"key":"10.1016\/j.xinn.2021.100091_bib16","doi-asserted-by":"crossref","first-page":"128907","DOI":"10.1155\/2013\/128907","article-title":"Serum AMH in physiology and pathology of male gonads","volume":"2013","author":"Matuszczak","year":"2013","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.xinn.2021.100091_bib17","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1210\/jc.2010-1207","article-title":"Changes in anti-mullerian hormone (AMH) throughout the life span: a population-based study of 1027 healthy males from birth (cord blood) to the age of 69 years","volume":"95","author":"Aksglaede","year":"2010","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xinn.2021.100091_bib18","doi-asserted-by":"crossref","first-page":"e70967","DOI":"10.1371\/journal.pone.0070967","article-title":"Elderly men have low levels of anti-mullerian hormone and inhibin B, but with high interpersonal variation: a cross-sectional study of the Sertoli cell hormones in 615 community-dwelling men","volume":"8","author":"Chong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.xinn.2021.100091_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/aja.aja_83_18","article-title":"Regulation of anti-Mullerian hormone (AMH) in males and the associations of serum AMH with the disorders of male fertility","volume":"21","author":"Xu","year":"2019","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.xinn.2021.100091_bib20","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1172\/JCI119653","article-title":"Hormonal and cellular regulation of Sertoli cell anti-Mullerian hormone production in the postnatal mouse","volume":"100","author":"AlAttar","year":"1997","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xinn.2021.100091_bib21","doi-asserted-by":"crossref","first-page":"e0179634","DOI":"10.1371\/journal.pone.0179634","article-title":"Serum variations of anti-mullerian hormone and total testosterone with aging in healthy adult Iranian men: a population-based study","volume":"12","author":"Ramezani Tehrani","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.xinn.2021.100091_bib22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1093\/humupd\/dmt062","article-title":"The physiology and clinical utility of anti-Mullerian hormone in women","volume":"20","author":"Dewailly","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.xinn.2021.100091_bib23","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.ogc.2004.08.005","article-title":"Fetal hormones and sexual differentiation","volume":"31","author":"Sobel","year":"2004","journal-title":"Obstet. Gynecol. Clin. North Am."},{"key":"10.1016\/j.xinn.2021.100091_bib24","first-page":"379","article-title":"Problems of fetal endocrinology - the gonadal and hypophyseal hormones","volume":"8","author":"Jost","year":"1953","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.xinn.2021.100091_bib25","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1447-0756.2010.01272.x","article-title":"Development of the genital ducts and external genitalia in the early human embryo","volume":"36","author":"Sajjad","year":"2010","journal-title":"J.\u00a0Obstet. Gynaecol. Res."},{"key":"10.1016\/j.xinn.2021.100091_bib26","first-page":"153","article-title":"The Sertoli cell - a hormonal target and \"super\" nurse for germ cells that determines testicular size","volume":"66","author":"Petersen","year":"2006","journal-title":"Horm. Res."},{"key":"10.1016\/j.xinn.2021.100091_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2559.1990.tb01086.x","article-title":"Sertoli-cell types in the Sertoli-cell-only syndrome - relationships between sertoli-cell morphology and etiology","volume":"16","author":"Nistal","year":"1990","journal-title":"Histopathology"},{"key":"10.1016\/j.xinn.2021.100091_bib28","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/me.2002-0186","article-title":"Follicle-stimulating hormone increases testicular anti-Mullerian hormone (AMH) production through Sertoli cell proliferation and a nonclassical cyclic adenosine 5 \u2019-monophosphate-mediated activation of the AMH gene","volume":"17","author":"Lukas-Croisier","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.xinn.2021.100091_bib29","first-page":"435","article-title":"Molecular control of immune\/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways","volume":"20","author":"McKay","year":"1999","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.xinn.2021.100091_bib30","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1128\/MCB.18.11.6653","article-title":"Direct interaction of SRY-related protein SOX9 and steroidogenic factor 1 regulates transcription of the human anti-Mullerian hormone gene","volume":"18","author":"De Santa Barbara","year":"1998","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.xinn.2021.100091_bib31","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0092-8674(00)81527-5","article-title":"Targeted mutagenesis of the endogenous mouse Mis gene promoter: in vivo definition of genetic pathways of vertebrate sexual development","volume":"99","author":"Arango","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.xinn.2021.100091_bib32","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0092-8674(94)90050-7","article-title":"Nuclear receptor steroidogenic factor-1 regulates the mullerian-inhibiting substance gene - a link to the sex determination cascade","volume":"77","author":"Shen","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.xinn.2021.100091_bib33","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1242\/dev.124.9.1799","article-title":"The nuclear receptor SF-1 mediates sexually dimorphic expression of Mullerian inhibiting substance, in vivo","volume":"124","author":"Giuili","year":"1997","journal-title":"Development"},{"key":"10.1016\/j.xinn.2021.100091_bib34","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1073\/pnas.97.4.1624","article-title":"Endogenous expression of Mullerian inhibiting substance in early postnatal rat Sertoli cells requires multiple steroidogenic factor-1 and GATA-4-binding sites","volume":"97","author":"Watanabe","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.xinn.2021.100091_bib35","first-page":"1388","article-title":"Transcription factor GATA-4 enhances Mullerian inhibiting substance gene transcription through a direct interaction with the nuclear receptor SF-1","volume":"13","author":"Tremblay","year":"1999","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.xinn.2021.100091_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/(SICI)1098-2795(200006)56:2<124::AID-MRD2>3.0.CO;2-J","article-title":"GATA-1 is a potential repressor of anti-Mullerian hormone expression during the establishment of puberty in the mouse","volume":"56","author":"Beau","year":"2000","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.xinn.2021.100091_bib37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/scdb.1998.0203","article-title":"The central role of Sertoli cells in spermatogenesis","volume":"9","author":"Griswold","year":"1998","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.xinn.2021.100091_bib38","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/endo-122-3-787","article-title":"Evidence from Sertoli cell-depleted rats indicates that spermatid number in adults depends on numbers of Sertoli cells produced during perinatal development","volume":"122","author":"Orth","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.xinn.2021.100091_bib39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.fertnstert.2015.10.017","article-title":"Antimullerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause","volume":"105","author":"Cui","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib40","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tem.2008.08.002","article-title":"Anti-Mullerian hormone and ovarian dysfunction","volume":"19","author":"Broekmans","year":"2008","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.xinn.2021.100091_bib41","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/humupd\/dmu020","article-title":"Anti-Mullerian hormone: ovarian reserve testing and its potential clinical implications","volume":"20","author":"Broer","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.xinn.2021.100091_bib42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.mce.2016.05.019","article-title":"Intra-cellular mechanism of anti-Mullerian hormone (AMH) in regulation of follicular development","volume":"433","author":"Hayes","year":"2016","journal-title":"Mol. Cell Enocrinol."},{"key":"10.1016\/j.xinn.2021.100091_bib43","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","article-title":"Elevated prenatal anti-Mullerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood","volume":"24","author":"Tata","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xinn.2021.100091_bib44","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1210\/en.2006-1265","article-title":"Increased oocyte degeneration and follicular atresia during the estrous cycle in anti-Mullerian hormone null mice","volume":"148","author":"Visser","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.xinn.2021.100091_bib45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.mce.2003.09.024","article-title":"Anti-Mullerian hormone and its role in ovarian function","volume":"211","author":"Gruijters","year":"2003","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.xinn.2021.100091_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/molehr\/gah015","article-title":"Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment","volume":"10","author":"Weenen","year":"2004","journal-title":"Mol. Hum. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib47","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/endo.143.3.8691","article-title":"Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary","volume":"143","author":"Durlinger","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/j.xinn.2021.100091_bib48","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/humrep\/del165","article-title":"Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro","volume":"21","author":"Carlsson","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib49","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humupd\/dmw027","article-title":"Interactions between androgens, FSH, anti-Mullerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.xinn.2021.100091_bib50","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/humrep\/del291","article-title":"Serum anti-Mullerian hormone throughout the human menstrual cycle","volume":"21","author":"La Marca","year":"2006","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib51","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0015-0282(99)00639-1","article-title":"Serum mullerian-inhibiting substance levels during normal menstrual cycles","volume":"73","author":"Cook","year":"2000","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib52","doi-asserted-by":"crossref","first-page":"10055","DOI":"10.1038\/ncomms10055","article-title":"Novel role for anti-Mullerian hormone in the regulation of GnRH neuron excitability and hormone secretion","volume":"7","author":"Cimino","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xinn.2021.100091_bib53","doi-asserted-by":"crossref","first-page":"E1688","DOI":"10.1073\/pnas.1620729114","article-title":"AMH\/MIS as a contraceptive that protects the ovarian reserve during chemotherapy","volume":"114","author":"Kano","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.xinn.2021.100091_bib54","doi-asserted-by":"crossref","first-page":"E1649","DOI":"10.1210\/jc.2011-3133","article-title":"Differential regulation of ovarian anti-mullerian hormone (AMH) by estradiol through alpha- and beta-estrogen receptors","volume":"97","author":"Grynberg","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xinn.2021.100091_bib55","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.fertnstert.2015.07.1161","article-title":"Dynamic antimullerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes","volume":"104","author":"Styer","year":"2015","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib56","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00404-016-4274-8","article-title":"Retrospective cohort study: AMH is the best ovarian reserve markers in predicting ovarian response but has unfavorable value in predicting clinical pregnancy in GnRH antagonist protocol","volume":"295","author":"Xu","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.xinn.2021.100091_bib57","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.maturitas.2017.04.018","article-title":"Anti-Mullerian hormone, follicle stimulating hormone, antral follicle count, and risk of menopause within 5 years","volume":"102","author":"Kim","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/j.xinn.2021.100091_bib58","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s40618-016-0521-x","article-title":"The use of serum anti-Mullerian hormone (AMH) levels and antral follicle count (AFC) to predict the number of oocytes collected and availability of embryos for cryopreservation in IVF","volume":"39","author":"Kotanidis","year":"2016","journal-title":"J.\u00a0Endocrinol. Invest."},{"key":"10.1016\/j.xinn.2021.100091_bib59","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.fertnstert.2007.06.023","article-title":"Serum antimullerian hormone levels remain stable throughout the menstrual cycle and after oral or vaginal administration of synthetic sex steroids","volume":"90","author":"Streuli","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib60","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.fertnstert.2013.01.132","article-title":"Variation in antimullerian hormone concentration during the menstrual cycle may change the clinical classification of the ovarian response","volume":"99","author":"Hadlow","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib61","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fendo.2018.00603","article-title":"The impact of the biological variability or assay performance on AMH measurements: a prospective cohort study with AMH tested on three analytical assay-platforms","volume":"9","author":"Bungum","year":"2018","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.xinn.2021.100091_bib62","doi-asserted-by":"crossref","first-page":"hox026","DOI":"10.1093\/hropen\/hox026","article-title":"The correlation between AMH assays differs depending on actual AMH levels","volume":"2017","author":"Magnusson","year":"2017","journal-title":"Hum. Reprod. Open"},{"key":"10.1016\/j.xinn.2021.100091_bib63","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1093\/humrep\/dew248","article-title":"Comparative evaluation of three new commercial immunoassays for anti-Mullerian hormone measurement","volume":"31","author":"Li","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib64","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.rbmo.2018.08.012","article-title":"Towards international standardization of immunoassays for Mullerian inhibiting substance\/anti-Mullerian hormone","volume":"37","author":"Ferguson","year":"2018","journal-title":"Reprod. Biomed. Online"},{"key":"10.1016\/j.xinn.2021.100091_bib65","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.fertnstert.2017.06.005","article-title":"The international glossary on infertility and fertility care, 2017","volume":"108","author":"Zegers-Hochschild","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib66","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.fertnstert.2012.11.029","article-title":"The aging ovary\u2013the poor granulosa cells","volume":"99","author":"Tatone","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib67","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1095\/biolreprod.103.015784","article-title":"Age-related changes in the ultrastructure of the resting follicle pool in human ovaries","volume":"70","author":"de Bruin","year":"2004","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib68","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/er.2009-0006","article-title":"Ovarian aging: mechanisms and clinical consequences","volume":"30","author":"Broekmans","year":"2009","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.xinn.2021.100091_bib69","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1093\/humrep\/deg507","article-title":"Evidence of apoptosis in human primordial and primary follicles","volume":"18","author":"Depalo","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib70","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.fertnstert.2004.06.075","article-title":"Apoptosis and active caspase-3 expression in human granulosa cells","volume":"83","author":"Glamoclija","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib71","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10815-014-0328-7","article-title":"Is AMH a regulator of follicular atresia?","volume":"31","author":"Seifer","year":"2014","journal-title":"J.\u00a0Assist Reprod. Genet."},{"key":"10.1016\/j.xinn.2021.100091_bib72","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.fertnstert.2013.01.139","article-title":"Peripubertal changes in circulating antimullerian hormone levels in girls","volume":"99","author":"Lashen","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib73","doi-asserted-by":"crossref","first-page":"e8772","DOI":"10.1371\/journal.pone.0008772","article-title":"Human ovarian reserve from conception to the menopause","volume":"5","author":"Wallace","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.xinn.2021.100091_bib74","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fendo.2018.00061","article-title":"Granulosa cell apoptosis in the ovarian follicle\u2013A changing view","volume":"9","author":"Regan","year":"2018","journal-title":"Front Endocrinol. (Lausanne)"},{"key":"10.1016\/j.xinn.2021.100091_bib75","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1093\/oxfordjournals.humrep.a137570","article-title":"Accelerated disappearance of ovarian follicles in midlife - implications for forecasting menopause","volume":"7","author":"Faddy","year":"1992","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib76","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.AOG.0000459864.68372.ec","article-title":"Committee opinion no. 618: ovarian reserve testing","volume":"125","author":"American College of Obstetricians and Gynecologists","year":"2015","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.xinn.2021.100091_bib77","doi-asserted-by":"crossref","first-page":"e22024","DOI":"10.1371\/journal.pone.0022024","article-title":"A validated model of serum anti-mullerian hormone from conception to menopause","volume":"6","author":"Kelsey","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.xinn.2021.100091_bib78","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.fertnstert.2014.12.093","article-title":"Testing and interpreting measures of ovarian reserve: a committee opinion","volume":"103","year":"2015","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib79","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1093\/humrep\/der106","article-title":"Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles","volume":"26","author":"Sunkara","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib80","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/humrep\/dev076","article-title":"Increased risk of preterm birth and low birthweight with very high number of oocytes following IVF: an analysis of 65 868 singleton live birth outcomes","volume":"30","author":"Sunkara","year":"2015","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib81","doi-asserted-by":"crossref","first-page":"352098","DOI":"10.1155\/2014\/352098","article-title":"Management of poor responders in IVF: is there anything new?","volume":"2014","author":"Ubaldi","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.xinn.2021.100091_bib82","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.fertnstert.2013.12.026","article-title":"Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles","volume":"101","author":"Steward","year":"2014","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib83","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.repbio.2014.03.004","article-title":"Anti-Mullerian hormone (AMH) is a strong predictor of live birth in women undergoing assisted reproductive technology","volume":"14","author":"Lukaszuk","year":"2014","journal-title":"Reprod. Biol."},{"key":"10.1016\/j.xinn.2021.100091_bib84","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.fertnstert.2017.10.021","article-title":"Antimullerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013","volume":"109","author":"Tal","year":"2018","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib85","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(08)60346-3","article-title":"Menopause","volume":"371","author":"Nelson","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.xinn.2021.100091_bib86","doi-asserted-by":"crossref","first-page":"e1862","DOI":"10.1210\/clinem\/dgz283","article-title":"Anti-Mullerian hormone and impending menopause in late reproductive age: the study of women\u2019s health across the nation","volume":"105","author":"Finkelstein","year":"2020","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xinn.2021.100091_bib87","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/humrep\/dey077","article-title":"Anti-Mullerian hormone levels and incidence of early natural menopause in a prospective study","volume":"33","author":"Bertone-Johnson","year":"2018","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib88","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/humrep\/dew112","article-title":"Does anti-Mullerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study","volume":"31","author":"Depmann","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib89","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/gme.0b013e318205e2ac","article-title":"Predicting age at menopause from serum antimullerian hormone concentration","volume":"18","author":"Tehrani","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.xinn.2021.100091_bib90","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1210\/jc.2011-3032","article-title":"Anti-Mullerian hormone as a predictor of time to menopause in late reproductive age women","volume":"97","author":"Freeman","year":"2012","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xinn.2021.100091_bib91","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.fertnstert.2004.11.029","article-title":"Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study","volume":"83","author":"van Rooij","year":"2005","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib92","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1210\/er.2018-00010","article-title":"At the crossroads of fate-somatic cell lineage specification in the fetal gonad","volume":"39","author":"Rotgers","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.xinn.2021.100091_bib93","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1016\/j.celrep.2019.02.069","article-title":"Dissecting cell lineage specification and sex fate determination in gonadal somatic cells using single-cell transcriptomics","volume":"26","author":"Stevant","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.xinn.2021.100091_bib94","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0378-5122(94)90052-3","article-title":"Sertoli-cell function declines earlier than Leydig-cell function in aging Japanese men","volume":"18","author":"Haji","year":"1994","journal-title":"Maturitas"},{"key":"10.1016\/j.xinn.2021.100091_bib95","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1651-2227.2011.02148.x","article-title":"Serum concentrations of anti-Mullerian hormone (AMH) in 95 patients with Klinefelter syndrome with or without cryptorchidism","volume":"100","author":"Aksglaede","year":"2011","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.xinn.2021.100091_bib96","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2265.2004.02051.x","article-title":"Altered serum profile of inhibin B, Pro-alphaC and anti-Mullerian hormone in prepubertal and pubertal boys with varicocele","volume":"60","author":"Trigo","year":"2004","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.xinn.2021.100091_bib97","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/09513590701672314","article-title":"Serum anti-Mullerian hormone levels differentiate control from subfertile men but not men with different causes of subfertility","volume":"24","author":"Goulis","year":"2008","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.xinn.2021.100091_bib98","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.repbio.2018.03.003","article-title":"Successful microdissection testicular sperm extraction for men with non-obstructive azoospermia","volume":"18","author":"Klami","year":"2018","journal-title":"Reprod. Biol."},{"key":"10.1016\/j.xinn.2021.100091_bib99","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/biolre\/ioy059","article-title":"Leydig cells: formation, function, and regulation","volume":"99","author":"Zirkin","year":"2018","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000475516","article-title":"The persistent mullerian duct syndrome: an update based upon a personal experience of 157 cases","volume":"11","author":"Picard","year":"2017","journal-title":"Sex Dev."},{"key":"10.1016\/j.xinn.2021.100091_bib101","first-page":"198698","article-title":"Anti-Mullerian hormone and its clinical use in pediatrics with special emphasis on disorders of sex development","volume":"2013","author":"Johansen","year":"2013","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.xinn.2021.100091_bib102","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.beem.2010.08.013","article-title":"Normal male sexual differentiation and aetiology of disorders of sex development","volume":"25","author":"Rey","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xinn.2021.100091_bib103","first-page":"337","article-title":"Evaluation and treatment of cryptorchidism: AUA guideline","volume":"192","author":"Kolon","year":"2014","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.xinn.2021.100091_bib104","doi-asserted-by":"crossref","first-page":"e1174","DOI":"10.1542\/peds.2012-2902","article-title":"Growth of spontaneously descended and surgically treated testes during early childhood","volume":"131","author":"Kollin","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.xinn.2021.100091_bib105","first-page":"257","article-title":"Long-term testicular volume after orchiopexy at diagnosis of acquired undescended testis","volume":"190","author":"van der Plas","year":"2013","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.xinn.2021.100091_bib106","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1210\/jc.2004-0542","article-title":"Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism","volume":"90","author":"Young","year":"2005","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xinn.2021.100091_bib107","first-page":"351","article-title":"Morphological and histometric study on the human Sertoli cell from birth to the onset of puberty","volume":"134","author":"Nistal","year":"1982","journal-title":"J.\u00a0Anat."},{"key":"10.1016\/j.xinn.2021.100091_bib108","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s12020-011-9551-5","article-title":"Serum AMH concentration as a marker evaluating gonadal function in boys operated on for unilateral cryptorchidism between 1st and 4th year of life","volume":"41","author":"Matuszczak","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.xinn.2021.100091_bib109","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00383-006-1646-3","article-title":"The effects of orchiopexy on serum anti-Mullerian hormone levels in unilateral cryptorchid infants","volume":"22","author":"Demircan","year":"2006","journal-title":"Pediatr. Surg. Int."},{"key":"10.1016\/j.xinn.2021.100091_bib110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mce.2003.09.011","article-title":"Anti-Mullerian hormone levels in serum from human foetuses and children: pattern and clinical interest","volume":"211","author":"Guibourdenche","year":"2003","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.xinn.2021.100091_bib111","first-page":"1","article-title":"Cryptorchidism--aspects of pathogenesis, histology and treatment","volume":"196","author":"Cortes","year":"1998","journal-title":"Scand. J. Urol. Nephrol. Suppl."},{"key":"10.1016\/j.xinn.2021.100091_bib112","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0090-4295(00)00560-4","article-title":"Early orchiopexy: prepubertal intratubular germ cell neoplasia and fertility outcome","volume":"56","author":"Engeler","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.xinn.2021.100091_bib113","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1542\/peds.98.4.676","article-title":"Paternity after unilateral cryptorchidism: a controlled study","volume":"98","author":"Lee","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.xinn.2021.100091_bib114","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.jpedsurg.2010.07.030","article-title":"What is new in cryptorchidism and hypospadias--a critical review on the testicular dysgenesis hypothesis","volume":"45","author":"Thorup","year":"2010","journal-title":"J.\u00a0Pediatr. Surg."},{"key":"10.1016\/j.xinn.2021.100091_bib115","first-page":"28","article-title":"Fertility after bilateral cryptorchidism. Evaluation by paternity, hormone, and semen data","volume":"55","author":"Lee","year":"2001","journal-title":"Horm. Res."},{"key":"10.1016\/j.xinn.2021.100091_bib116","first-page":"1188","article-title":"Quantitative histology of germ cells in the undescended testes of human fetuses, neonates and infants","volume":"154","author":"Cortes","year":"1995","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.xinn.2021.100091_bib117","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib118","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib119","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"Andersen","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib120","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.fertnstert.2011.03.071","article-title":"Random anti-Mullerian hormone (AMH) is a predictor of ovarian response in women with elevated baseline early follicular follicle-stimulating hormone levels","volume":"95","author":"Buyuk","year":"2011","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib121","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.fertnstert.2008.08.127","article-title":"Circulating basal anti-Mullerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization","volume":"92","author":"Nardo","year":"2009","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib122","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humrep\/deg042","article-title":"Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3","volume":"18","author":"Fanchin","year":"2003","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib123","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2174\/138920112799361972","article-title":"Possibilities and limits of ovarian reserve testing in ART","volume":"13","author":"La Marca","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.xinn.2021.100091_bib124","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.fertnstert.2012.09.036","article-title":"Testing and interpreting measures of ovarian reserve: a committee opinion","volume":"98","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/09513590.2013.860124","article-title":"Dynamics of anti-Mullerian hormone during controlled ovarian stimulation","volume":"30","author":"Bottcher","year":"2014","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.xinn.2021.100091_bib126","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1210\/en.2018-00609","article-title":"Oocyte-derived factors (GDF9 and BMP15) and FSH regulate AMH expression via modulation of H3K27AC in granulosa cells","volume":"159","author":"Roy","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.xinn.2021.100091_bib127","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.fertnstert.2015.04.044","article-title":"Changes in antimullerian hormone levels in early pregnancy are associated with preterm birth","volume":"104","author":"Stegmann","year":"2015","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib128","first-page":"346","article-title":"AUA guideline on the diagnosis and treatment of cryptorchidism","volume":"192","author":"Pastuszak","year":"2014","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.xinn.2021.100091_bib129","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1055\/s-0032-1324719","article-title":"Testicular anti-mullerian hormone: clinical applications in DSD","volume":"30","author":"Josso","year":"2012","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.xinn.2021.100091_bib130","first-page":"203","article-title":"An update on the clinical assessment of the infertile male (vol 66, pg 691, 2011)","volume":"67","author":"Esteves","year":"2012","journal-title":"Clinics"},{"key":"10.1016\/j.xinn.2021.100091_bib131","first-page":"E796","article-title":"Anti-Mullerian hormone-to-testosterone ratio is predictive of positive sperm retrieval in men with idiopathic non-obstructive azoospermia","volume":"199","author":"Alfano","year":"2018","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.xinn.2021.100091_bib132","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/humupd\/dmq024","article-title":"Inhibin B and anti-Mullerian hormone as markers of persistent spermatogenesis in men with non-obstructive azoospermia: a meta-analysis of diagnostic accuracy studies","volume":"16","author":"Toulis","year":"2010","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.xinn.2021.100091_bib133","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.fertnstert.2009.11.046","article-title":"Seminal plasma levels of anti-Mullerian hormone and inhibin B are not predictive of testicular sperm retrieval in nonobstructive azoospermia: a study of 139 men","volume":"94","author":"Mitchell","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib134","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.fertnstert.2007.03.032","article-title":"Significance of inhibin B and anti-Mullerian hormone in seminal plasma: a preliminary study","volume":"89","author":"Duvilla","year":"2008","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib135","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib136","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.steroids.2013.05.004","article-title":"Animal models of the polycystic ovary syndrome phenotype","volume":"78","author":"Padmanabhan","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.xinn.2021.100091_bib137","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12958-017-0231-z","article-title":"Animal models of hyperandrogenism and ovarian morphology changes as features of polycystic ovary syndrome: a systematic review","volume":"15","author":"Paixao","year":"2017","journal-title":"Reprod. Biol. Endocrine"},{"key":"10.1016\/j.xinn.2021.100091_bib138","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0030-1249020","article-title":"Very high frequency of the polymorphism for the insulin receptor substrate 1 (IRS-1) at codon 972 (glycine972arginine) in southern Italian women with polycystic ovary syndrome","volume":"42","author":"Pappalardo","year":"2010","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.xinn.2021.100091_bib139","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40618-016-0569-7","article-title":"Gly972Arg of IRS-1 and Lys121Gln of PC-1 polymorphisms act in opposite way in polycystic ovary syndrome","volume":"40","author":"Pappalardo","year":"2017","journal-title":"J.\u00a0Endocrinol. Invest."},{"key":"10.1016\/j.xinn.2021.100091_bib140","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12929-018-0452-2","article-title":"rs4889 polymorphism in KISS1 gene, its effect on polycystic ovary syndrome development and anthropometric and hormonal parameters in Saudi women","volume":"25","author":"Albalawi","year":"2018","journal-title":"J.\u00a0Biomed. Sci."},{"key":"10.1016\/j.xinn.2021.100091_bib141","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12020-018-1609-1","article-title":"Kisspeptin and LH pulsatile temporal coupling in PCOS patients","volume":"61","author":"Katulski","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.xinn.2021.100091_bib142","first-page":"367","article-title":"Kisspeptin in the hypothalamus of 2 rat models of polycystic ovary syndrome","volume":"158","author":"Osuka","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.xinn.2021.100091_bib143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2012.05.049","article-title":"Hypothalamic kiss1 mRNA and kisspeptin immunoreactivity are reduced in a rat model of polycystic ovary syndrome (PCOS)","volume":"1467","author":"Brown","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.xinn.2021.100091_bib144","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1210\/en.2014-1609","article-title":"Prenatal testosterone treatment leads to changes in the morphology of KNDy neurons, their inputs, and projections to GnRH cells in female sheep","volume":"156","author":"Cernea","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.xinn.2021.100091_bib145","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/rmb2.12262","article-title":"Animal models of polycystic ovary syndrome: a review of hormone-induced rodent models focused on hypothalamus-pituitary-ovary axis and neuropeptides","volume":"18","author":"Osuka","year":"2019","journal-title":"Reprod. Med. Biol."},{"key":"10.1016\/j.xinn.2021.100091_bib146","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/humrep\/deq088","article-title":"Is polycystic ovary syndrome an exception for reproductive aging?","volume":"25","author":"Tehrani","year":"2010","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib147","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0140-6736(03)14410-8","article-title":"Formation and early development of follicles in the polycystic ovary","volume":"362","author":"Webber","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.xinn.2021.100091_bib148","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/cen.13479","article-title":"Age-stratified thresholds of anti-Mullerian hormone improve prediction of polycystic ovary syndrome over a population-based threshold","volume":"87","author":"Dewailly","year":"2017","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.xinn.2021.100091_bib149","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1093\/humrep\/des213","article-title":"Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?","volume":"27","author":"Eilertsen","year":"2012","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.xinn.2021.100091_bib150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40618-017-0728-5","article-title":"Does a male polycystic ovarian syndrome equivalent exist?","volume":"41","author":"Cannarella","year":"2018","journal-title":"J.\u00a0Endocrinol. Invest."},{"key":"10.1016\/j.xinn.2021.100091_bib151","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1001\/jamadermatol.2016.1776","article-title":"A comparison of the hormonal profile of early androgenetic alopecia in men with the phenotypic equivalent of polycystic ovarian syndrome in women","volume":"152","author":"Sanke","year":"2016","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.xinn.2021.100091_bib152","first-page":"79","article-title":"Male equivalent polycystic ovarian syndrome: hormonal, metabolic, and clinical aspects","volume":"14","author":"Di Guardo","year":"2020","journal-title":"Int. J. Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib153","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/s41591-019-0666-1","article-title":"Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome","volume":"25","author":"Risal","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xinn.2021.100091_bib154","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S2213-8587(15)00039-X","article-title":"Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults","volume":"3","author":"Anderson","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.xinn.2021.100091_bib155","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/0002-9378(92)91335-8","article-title":"Early menopause in long-term survivors of cancer during adolescence","volume":"166","author":"Byrne","year":"1992","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.xinn.2021.100091_bib156","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejogrb.2012.11.021","article-title":"Anti-Mullerian hormone as a marker of ovarian reserve following chemotherapy in patients with gestational trophoblastic neoplasia","volume":"167","author":"Iwase","year":"2013","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"10.1016\/j.xinn.2021.100091_bib157","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1210\/jc.2010-2582","article-title":"Pretreatment serum anti-mullerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer","volume":"96","author":"Anderson","year":"2011","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xinn.2021.100091_bib158","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1210\/en.2015-1310","article-title":"Anti-Mullerian hormone is a marker for chemotherapy-induced testicular toxicity","volume":"156","author":"Levi","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/j.xinn.2021.100091_bib159","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/ijc.29532","article-title":"The clinical utility of serum anti-Mullerian hormone in the follow-up of ovarian adult-type granulosa cell tumors\u2013A comparative study with inhibin B","volume":"137","author":"Farkkila","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xinn.2021.100091_bib160","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/hupa.2000.18498","article-title":"Anti-Mullerian hormone is a specific marker of Sertoli- and granulosa-cell origin in gonadal tumors","volume":"31","author":"Rey","year":"2000","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.xinn.2021.100091_bib161","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ygyno.2016.11.018","article-title":"Roles of human epididymis protein 4, carbohydrate antigen 125, inhibin B and anti-Mullerian hormone in the differential diagnosis and follow-up of ovarian granulosa cell tumors","volume":"144","author":"Haltia","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.xinn.2021.100091_bib162","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00120-007-1556-6","article-title":"Sclerosing Sertoli cell tumor of the testis - a tumor rare tumor - case report and review of the literature on the subtypes of Sertoli-cell","volume":"46","author":"Werther","year":"2007","journal-title":"Urologe A"},{"key":"10.1016\/j.xinn.2021.100091_bib163","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12917-015-0487-5","article-title":"Anti-Mullerian hormone: a potentially useful biomarker for the diagnosis of canine Sertoli cell tumours","volume":"11","author":"Holst","year":"2015","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.xinn.2021.100091_bib164","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jcpa.2011.03.011","article-title":"Immunohistochemical evaluation of the expression of anti-mullerian hormone in mature, immature and neoplastic canine sertoli cells","volume":"146","author":"Banco","year":"2012","journal-title":"J.\u00a0Comp. Pathol."},{"key":"10.1016\/j.xinn.2021.100091_bib165","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13633-016-0038-2","article-title":"Anti-Mullerian hormone as a marker of steroid and gonadotropin action in the testis of children and adolescents with disorders of the gonadal axis","volume":"2016","author":"Edelsztein","year":"2016","journal-title":"Int. J. Pediatr. Endocrinol."},{"key":"10.1016\/j.xinn.2021.100091_bib166","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.fertnstert.2012.02.020","article-title":"Circulating antimullerian hormone levels in boys decline during early puberty and correlate with inhibin B","volume":"97","author":"Hero","year":"2012","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.xinn.2021.100091_bib167","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.2047-2927.2012.00008.x","article-title":"Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach","volume":"1","author":"Rey","year":"2013","journal-title":"Andrology"},{"key":"10.1016\/j.xinn.2021.100091_bib168","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1210\/jc.2010-1535","article-title":"Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty","volume":"95","author":"Coutant","year":"2010","journal-title":"J.\u00a0Clin. Endocrinol. Metab."},{"key":"10.1016\/j.xinn.2021.100091_bib169","article-title":"Plasma inhibin B and antimullerian hormone concentrations in boys: discriminating between congenital hypogonadotropic hypogonadism and constitutional pubertal delay","volume":"16","author":"Adan","year":"2010","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.xinn.2021.100091_bib170","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach","volume":"19","author":"Broer","year":"2013","journal-title":"Hum. Reprod. Update"}],"container-title":["The Innovation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666675821000163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666675821000163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:46:57Z","timestamp":1763005617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666675821000163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":170,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2666675821000163"],"URL":"https:\/\/doi.org\/10.1016\/j.xinn.2021.100091","relation":{},"ISSN":["2666-6758"],"issn-type":[{"value":"2666-6758","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Applications of Serum Anti-M\u00fcllerian Hormone Measurements in Both Males and Females: An Update","name":"articletitle","label":"Article Title"},{"value":"The Innovation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xinn.2021.100091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021","name":"copyright","label":"Copyright"}],"article-number":"100091"}}